Vivani Medical (Nasdaq:VANI) announced today that it successfully administered the first GLP-1 implant in its LIBERATE-1 ...

By now, you likely know which foods and drinks can help prevent Type 2 diabetes—but did you know that the order in which you ...

GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Vivani Medical (VANI) announced the successful administration of its first GLP-1 or exenatide, implant in the LIBERATE-1 clinical trial. This ...

With GLP-1 weight loss comes muscle loss. Gyms and personal trainers are rising to the challenge to help people build it back ...

Stopping GLP-1 receptor agonists 14 days prior to total hip or knee arthroplasty may reduce several key risk factors ...

McDonald's strategy emphasizes its competitive strengths through a "MCD" framework: relevant marketing, core menu development, and the four D's: digital, drive-thru, delivery, and development.

Financial Highlights Total End of Period Subscribers of 3.3 million, including 92 thousand End of Period Clinical SubscribersRevenues of $184.4 million; Subscription Revenues down ...

Researchers from Universitatsklinikum Heidelberg presented data from a study that investigated the role of strawberry notch homolog 1 (SBNO1) in the development of hepatocellular carcinoma (HCC) and ...